Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:12 pm Purchase | 2026-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 2,852,698 9.800% | 1,576,103 (+123.46%) | Filing History |
| 2026-05-06 11:30 am Purchase | 2026-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 4,303,188 15.000% | 1,266,427 (+41.70%) | Filing History |
| 2026-04-17 09:00 am Purchase | 2026-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | Two Seas Capital LP | 1,959,178 6.800% | 1,959,178 (New Position) | Filing History |
| 2026-03-27 10:48 am Sale | 2026-03-13 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 0 0.000% | -1,027,089 (Position Closed) | Filing History |
| 2026-03-06 10:05 am Purchase | 2026-02-27 | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 3,036,761 11.100% | 2,586,147 (+573.92%) | Filing History |
| 2026-02-13 5:17 pm Sale | 2025-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | G1 Execution Services, LLC | 809,967 4.000% | -425,897 (-34.46%) | Filing History |
| 2026-01-30 2:20 pm Purchase | 2025-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 1,027,089 5.040% | 78,442 (+8.27%) | Filing History |
| 2025-11-14 4:31 pm Sale | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Nantahala Capital Management, LLC | 418,522 2.200% | -291,239 (-41.03%) | Filing History |
| 2025-11-14 4:23 pm Sale | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II, LLC | 0 0.000% | -1,933,333 (Position Closed) | Filing History |
| 2025-11-13 5:45 pm Purchase | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | G1 Execution Services, LLC | 1,235,864 6.300% | 1,235,864 (New Position) | Filing History |
| 2025-10-31 11:05 am Purchase | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 948,647 4.980% | 145,789 (+18.16%) | Filing History |
| 2025-10-28 4:10 pm Sale | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Integrated Core Strategies (US) LLC | 570,994 3.000% | -361,869 (-38.79%) | Filing History |
| 2025-08-14 4:45 pm Purchase | 2025-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | Nantahala Capital Management, LLC | 709,761 5.720% | 709,761 (New Position) | Filing History |
| 2025-08-14 4:14 pm Purchase | 2025-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II, LLC | 1,933,333 9.300% | 596,910 (+44.66%) | Filing History |
| 2025-07-18 12:10 pm Sale | 2025-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock, Inc. BLK | 203,017 1.600% | -632,183 (-75.69%) | Filing History |
| 2025-07-09 4:39 pm Purchase | 2025-07-01 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 1,276,595 7.400% | 1,094,280 (+600.21%) | Filing History |
| 2025-07-03 2:07 pm Purchase | 2025-06-27 | 13G | NEKTAR THERAPEUTICS NKTR | Integrated Core Strategies (US) LLC | 932,863 5.400% | 932,863 (New Position) | Filing History |
| 2025-05-15 3:35 pm Sale | 2025-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | SAMLYN CAPITAL, LLC | 0 0.000% | -644,470 (Position Closed) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock, Inc. BLK | 835,200 6.700% | -229,423 (-21.55%) | Filing History |
| 2025-02-14 1:49 pm Purchase | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | SAMLYN CAPITAL, LLC | 644,470 5.200% | 644,470 (New Position) | Filing History |